STOCK-BASED COMPENSATION (Details) $ in Thousands |
1 Months Ended | 3 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2022
USD ($)
director
|
Mar. 31, 2022
USD ($)
|
Mar. 31, 2021
USD ($)
|
|
| Stock-based compensation expense related to stock-based awards | |||
| Total stock-based compensation expense | $ 3,207 | $ 2,639 | |
| Extended exercise period, number of members of Board of Directors | director | 2 | ||
| Incremental stock-based compensation expense | $ 800 | ||
| Selling, general and administrative | |||
| Stock-based compensation expense related to stock-based awards | |||
| Total stock-based compensation expense | 2,739 | 2,053 | |
| Research and development expense | |||
| Stock-based compensation expense related to stock-based awards | |||
| Total stock-based compensation expense | $ 468 | $ 586 | |
| X | ||||||||||
- Definition Represents the number of members of the board of directors for which exercise period has been extended. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition An excess of the fair value of the modified award over the fair value of the award immediately before the modification. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|